About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 715 record(s)
Req # A-2017-000001
All releasable product information for the following Natural Product Numbers (NPNs): 80043696, 80046986, 80047226, 80047528, 80049401, 80053145, 80056103, 80056346, 80060345, 80070583, 80071855, 80075493, 80075688, 80067260, 80073271.Organization: Health Canada
March 2023
Req # A-2017-000107
The New Drug Submission, Supplemental New Drug Submission or similar submission from the drug company to obtain approval for using Anafranil / Altius Clomipramine in the treatment of Obsessive Compulsive Disorder. The medical review of that…Organization: Health Canada
March 2023
Req # A-2018-000175
Drug submission information for Tylenol Extra Strength Gel Caps 500 mg Drug Identification Number (DIN) 00863270.Organization: Health Canada
March 2023
Req # A-2018-001598
Module 1 along with the reviewers note of the INTELLI-SEVELAMER 800 MG tablets New Drug Submission (NDS) Control No: 222726 - DIN 02484110 for INTELLIPHARM INC.Organization: Health Canada
March 2023
Req # A-2019-001941
Letters, notices, and email correspondence issued to Cannabis Act licence holders regarding non-compliance with the promotion prohibitions under the Cannabis Act between January 1, 2019 and February 1, 2020.Organization: Health Canada
March 2023
Req # A-2021-000235
All briefing provided to the Minister of Health regarding designated quarantine facilities for travellers. Timeframe: November 1, 2019 to May 17, 2021.Organization: Health Canada
March 2023
Req # A-2021-000562
The documentation or studies that Health Canada based itself on to issue incident report RA-75309, dated April 2, 2021, titled. All documents containing the results from the preliminary analysis completed by Health Canada in this regard.Organization: Health Canada
March 2023
Req # A-2021-001315
Summary basis of decision and Instruction For Use (IFU) for Mirasol Pathogen Reduction Technology System model No. 106324.Organization: Health Canada
March 2023
Req # A-2021-001688
All Task Authorizations, for each COVID-19 vaccination advertisement campaign, for the time period of September 2020 to December 22, 2021.Organization: Health Canada
March 2023
Req # A-2021-002144
Records for the service agreement between the Public Health Agency of Canada (PHAC) and Service Canada, managed by Health Canada, for the toll-free lines 1-833-784-4397 and 1-844-280-5020 as well as names of employees, description of their roles,…Organization: Health Canada
March 2023